Phase 2a Clinical Trial of HL237 for Rheumatoid Arthritis

NCT04638426 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: HL237 tablet
DRUG: Placebo of HL237 tablet

Sponsor

Hanlim Pharm. Co., Ltd.